From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...

This year's Super Bowl commercials relied on comic relief and highlighted noncontroversial topics, like streaming and entertainment.

Novo Nordisk called out suppliers of compounded weight loss drugs following Hims & Hers’ controversial Super Bowl ad.

But according to a new weight loss survey from Everyday Health, neither of these classic techniques topped the list of tactics that helped survey respondents successfully lose weight. Instead ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

Turmeric and honey contain beneficial compounds that can help reduce inflammation, improve metabolic health, and aid in ...

Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NYSE: NVO), famously the company behind Wegovy, and ...

Jim Cramer, the host of Mad Money, recently took a deep dive into the challenges facing the consumer packaged goods sector, ...

Hims is a US-based telehealth company offering online prescription medication, over-the-counter drugs, and personal care ...